Back to Faculty
Faculty

Matthew Hoptman

PhD
Research Associate Professor
NYU Grossman School of Medicine

Dr. Hoptman is a research scientist at Nathan Kline Institute and an Associate Professor of Psychiatry at NYU Langone Medical Center. He received his PhD in Biopsychology in 1991 from the University of Chicago. He has been working at NKI since 1994 and has had a faculty appointment at NYU Medical Center since that time. His research focus is on impulsivity, aggression, and suicidality in schizophrenia as relates to brain functional and structural connectivity, and he is interested in integrating imaging methods, including MRI, EEG, and neuromodulation. He is a charter member of the Association for Psychological Science and is a member of the Society of Biological Psychiatry, Society for Research in Psychopathology, and the Society for Neuroscience. He has served on numerous NIH grant review panels and has been funded by NIH, NARSAD, and the American Foundation for Suicide Prevention, including a current NIMH R01 grant on emotional impulsivity and suicidal ideation and behavior in schizophrenia and depression. He has also served as guest editor on two special issues for Frontiers in Psychiatry.

2026 Sessions

Suicide Risk Reconsidered: Brain, Biology, and Digital Influence Factors Every Psychiatrist Should Know

Contemporary suicide risk is shaped by factors that extend beyond symptoms alone. This rapid-fire session will address three evolving contributors to suicidal thoughts and behaviors: brain-based functionality identified through neuroscience research; hormonal influences on mood, cognition, and behavior across the lifespan; and the growing presence of AI chatbots in patients’ mental health decision-making. Faculty will provide practical guidance on identifying these contributors to suicide, incorporating targeted screening into assessments, and adapting treatment plans accordingly. Clinical examples will highlight how integrating biological and digital awareness can strengthen suicide prevention efforts.<br><br>Session developed in partnership with the American Foundation for Suicide Prevention (AFSP).

Speaker

Friday, September 18 3:45–4:45 PM
Room 211-213
AFSP Partner Session
Steering Committee

Steven Chan

MD, MBA, FAPA, FAMIA
Clinical Associate Professor (Affiliated)
Stanford University School of Medicine, Stanford, California

Steven Chan is a triple board-certified clinical informaticist, psychiatrist, and addiction medicine physician. He serves as Clinical Associate Professor at Stanford University School of Medicine and Immediate Past Chair of the Committee on Innovation at the American Psychiatric Association. Steven’s research and ideas have been featured in publications such as JAMA, Telemedicine and e-Health, JMIR, and Wired, and media appearances on PBS and NPR. He is a sought-after national speaker, having presented at Fortune 50 companies like Google headquarters.

He serves as Co-Director of Frontier Technology Lab in Stanford Engineering. At Stanford Psychiatry TechHub, he serves on the Leadership Committee. He additionally volunteers on the Board of Directors at Mental Health America.

In addition to his academic and clinical roles, Steven is the Chief Technology Officer and co-founder of AsyncHealth, a University of California-backed digital mental health AI agent startup supported by Berkeley SkyDeck PAD-13 and the National Science Foundation’s Innovation Corps (NSF i-Corps). Steven’s contributions to the field of digital mental health have made him a respected figure in both academic and industry circles.

Faculty

Tory Eisenlohr-Moul

PhD
Professor of Psychiatry and Behavioral Neuroscience
University of Chicago
Faculty

Matthew Hoptman

PhD
Research Associate Professor
NYU Grossman School of Medicine

Dr. Hoptman is a research scientist at Nathan Kline Institute and an Associate Professor of Psychiatry at NYU Langone Medical Center. He received his PhD in Biopsychology in 1991 from the University of Chicago. He has been working at NKI since 1994 and has had a faculty appointment at NYU Medical Center since that time. His research focus is on impulsivity, aggression, and suicidality in schizophrenia as relates to brain functional and structural connectivity, and he is interested in integrating imaging methods, including MRI, EEG, and neuromodulation. He is a charter member of the Association for Psychological Science and is a member of the Society of Biological Psychiatry, Society for Research in Psychopathology, and the Society for Neuroscience. He has served on numerous NIH grant review panels and has been funded by NIH, NARSAD, and the American Foundation for Suicide Prevention, including a current NIMH R01 grant on emotional impulsivity and suicidal ideation and behavior in schizophrenia and depression. He has also served as guest editor on two special issues for Frontiers in Psychiatry.
Back to top